HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assays], Molecular Assays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing

HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assays], Molecular Assays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing}]), By Product and Services (Instruments, Reagents and Consumables, Software, Services), By Application (Diagnostics, Research), By End-use (Hospitals, Academic and Research Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

The HLA typing for transplant market is poised to grow at a strong rate over the coming time period owing to the rising demand for organ transplantation, and technological advancements in the field of medicine. HLA or human leukocyte antigens are proteins that people inherit from their parents. HLA typing is utilized to match patients and donors for bone marrow transplants. It is basically a type of genetic test which is used for identifying specific individual variations in the immune system of a person.

The process is crucial to identify who can donate cord blood, bone marrow, or an organ to an individual who required a transplant. In fact, the selection of the ideal donor is generally based on high-resolution HLA typing. HLA typing is also referred as HLA matching.



Additionally, HLA matching is significant for transplant. A close match between a donor’s as well as a patient’s HLA markers is crucial for a successful transplant result. Likewise, the HLA matching encourages the growth and development of new healthy blood cells which are known as engraftment. It further decreases the risk of a post-transplant complication referred as GVHD (graft-versus-host) disease.



HLA typing for transplant market is divided into segments in terms of technology, products & services, application, end-use, and regional landscape.

Based on technology, the HLA typing for transplant market is classified into molecular assays and non-molecular assays. Among these, non-molecular assays segment accounted for market share of nearly 18.5% with estimates expecting it to register am momentous growth trend.

With respect to product & services, the HLA typing for transplant market is categorized into services, software, reagents and consumables, and instruments. Among these, the services segment will have a significant share over the forecast time period. In 2019, the segment accounted for approximately $84.9 million and is expected to register momentous gains over the coming years.



Based on application, the HLA typing for transplant market is divided into research and diagnostics. Among these, diagnostics application segment accounted for a market share of 77.8% and will continue to showcase appreciative growth over the coming years.



In terms of end-use, the overall HLA typing for transplant market is bifurcated into academic and research institutes, diagnostic labs, and hospitals. Among these, diagnostic labs segment will account for substantial gains over the coming years. In 2019, the diagnostic labs segment accounted for revenue of $315.2 million.

From a regional frame of reference, Latin America HLA typing for transplant market will reach approximately $40.6 million by the end of the analysis timeline. Middle East and Africa will witness substantial growth over the coming years. In 2019, MEA HLA typing for transplant market generated a revenue of nearly $10.1 million and will continue its growth status.